Wird geladen...
Revisiting the IGF-1R as a breast cancer target
The type I insulin-like growth factor-1 receptor is a well-described target in breast cancer and multiple clinical trials examining insulin-like growth factor-1 receptor have been completed. Unfortunately, monoclonal antibodies and tyrosine kinase inhibitors targeting insulin-like growth factor-1 re...
Gespeichert in:
| Veröffentlicht in: | NPJ Precis Oncol |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Nature Publishing Group UK
2017
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5687252/ https://ncbi.nlm.nih.gov/pubmed/29152592 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41698-017-0017-y |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|